Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease

Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative therapy for patients suffering from hematological malignancies via the donor immune system driven graft-versus-leukemia effect. However, the therapy is mainly limited by severe acute and chronic graft-versus-host...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Lukas M., Zeiser, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635802/
https://www.ncbi.nlm.nih.gov/pubmed/34868001
http://dx.doi.org/10.3389/fimmu.2021.760199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635802/
https://www.ncbi.nlm.nih.gov/pubmed/34868001
http://dx.doi.org/10.3389/fimmu.2021.760199

Ejemplares similares